The Relapsed AML 2001/01, 02 Study for children with relapsed acute myeloid leukaemia or initially resistant disease has improved outcome
2011
Abstract
Relapse of acute myeloid leukaemia (AML) or AML initially resistant to treatment is extremely prognostically infavourable. Between VII/2001 and III/2009 in the Czech Republic, twenty patients aged 0-18 years with this diagnosis were treated as part of the international Relapsed AML 2001/01 study.
Treatment in the Relapsed AML 2001 study improved the prognosis of children with relapsed AML in the Czech Republic compared to the previous period 1993-2001.